Revenue: The sum of all revenue fields included for a company's operating activities.
ANI Pharmaceuticals, Inc. (ANIP) had Revenue of $247.06M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$247.06M |
$27.49M |
|
$100.27M |
|
$146.79M |
|
$212.29M |
|
$34.77M |
|
$-3.29M |
|
$31.48M |
|
$31.48M |
|
$27.49M |
|
$27.49M |
|
$27.49M |
|
$27.49M |
|
$34.77M |
|
-- |
|
20.69M |
|
21.77M |
|
$1.24 |
|
$1.18 |
|
| Balance Sheet Financials | |
$753.12M |
|
$62.48M |
|
$687.26M |
|
$1.44B |
|
$278.11M |
|
$599.77M |
|
$621.54M |
|
$899.65M |
|
$540.72M |
|
$-1.28M |
|
$540.72M |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|